Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A Case-Control Study by Gheibipour, Hamid et al.
International Journal of Epidemiologic Research
© 2019 The Author(s); Published by Shahrekord University of Medical Sciences. This is an open-access article distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
2019 Autumn;6(4):144-148doi:10.15171/ijer.2019.25
Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A 
Case-Control Study
Hamid Gheibipour1 ID , Ghorbanali Rahimian2 ID , Ali Ahmadi1,3* ID
1Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
2Cellular and Molecular Research Center, School of Medicine, Shahrekord University of Medical Sciences,
Shahrekord, Iran
3Department of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, 
Shahrekord, Iran
http://ijer.skums.ac.ir
Original Article
Abstract
Background and aims: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) which 
involves the rectum and colonic mucosa, and is often constantly expanding. Few data are available on 
risk factors in Chaharmahal and Bakhtiari province. Therefore, the aim of this study was to investigate 
the association between potential risk factors and UC in Shahrekord.
Methods: A case-control study was conducted on patients diagnosed with UC. Overall, 27 new cases 
of UC and 54 healthy controls in the age range of 20–80 years were studied. Participants were recruited 
from Pathologic Centers in Shahrekord in 2018. Chi-square test and t test and were used. Logistic 
regression model was employed to analyze the association between risk factors and UC disease.
Results: The mean age at diagnosis was 41.74 years (SD: 7.16 years) and 44.94 years (SD: 6.67 
years) for case and control subjects, respectively. Moreover, univariate and multiple odds ratio (OR) 
showed that there was no significant association between UC and any of the risk factors including 
gender, marital status, education, diastolic blood pressure, history of diabetes, history of hypertension, 
permanent use of piped water, night shift work, history of thyroid diseases, depression, history of fatty 
liver disease, history of kidney stones, and sleep time and wake-up time in the morning.
Conclusion: Generally, no significant association was observed between UC and the variables in the 
present study. Thus, further studies with larger sample size are necessary to better understand the other 
risk factors and environmental determinants of UC.
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Introduction
Ulcerative colitis (UC) is a chronic inflammatory bowel 
disease (IBD) which involves the rectum and colonic 
mucosa, and is often constantly expanding.1 UC is 
characterized by diarrhoea, weight loss, pain in the lower 
left abdomen, rectal bleeding,2 and remission and frequent 
relapses.3 The disease can also lead to complication, surgery, 
hospitalization, and death. Moreover, it greatly influences 
the activity and quality of life of the patients.4,5 Although 
the etiology of UC has not yet been well known, it seems 
that genetic, environmental, and immunoregulatory 
factors affect it.6,7 The worldwide incidence and prevalence 
of IBD is rising, and the incidence is higher in industrialised 
countries compared to developing countries, despite 
limited information from developing countries.8 The 
geographical variability and rising incidence of UC suggest 
that environmental factors are involved in the etiology of 
the IBD8,9; however, limited information is available in this 
regard.10 Furthermore, few data are available on  the risk 
factors associated in Chaharmahal and Bakhtiari Province. 
Therefore, the purpose of this study was to investigate 
the association between prediagnostic risk factors and the 
risk of UC in Shahrekord, Chaharmahal and Bakhtiari 
province, Iran.
Materials and Methods 
A case-control study was conducted on the patients 
diagnosed with UC. Overall, 27 new cases diagnosed with 
UC and 54 healthy controls in the age range of 20–80 years 
were studied. Participants were recruited from Pathologic 
Centers in Shahrekord in 2018. The medical records of all 
cases were reviewed by gastroenterologists to confirm the 
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diagnosis. Control subjects were neighbours of UC patients 
and people who had referred to Shahrekord Cohort Study. 
In addition, controls were frequency-matched to cases by 
age and sex. Private face-to-face interviews were conducted 
by two trained interviewers using a checklist verified by 
gastroenterologists and one epidemiologist. Participants 
completed the checklist on demographic characteristics, 
age of onset of the symptoms, gender, marital status, 
education, diastolic blood pressure, history of diabetes, 
history of hypertension, permanent use of piped water, 
night shift work, history of thyroid diseases, depression, 
history of fatty liver disease, history of kidney stones, sleep 
time, wake-up time in the morning, and night-time sleep 
duration. Prior to the enrolment, informed consent was 
obtained from each participant. 
Statistical Analysis
Categorical variables were reported as frequency and 
percentage. Continuous variables were presented as mean 
and standard deviation (SD). In addition, t test and chi-
square test were used. Logistic regression was also employed 
to analyze the association between risk factors and UC 
disease. Multiple regression was also performed to adjust 
the confounders. Odds ratios (ORs) and their respective 
95% confidence intervals (CIs) were estimated. A P value 
less than 0.5 was regarded as statistically significant. All 
statistical analyses were performed using SPSS, version 
21.0 (SPSS Inc., Chicago, IL, USA).
Results
Demographic and behavioural characteristics of study 
population are shown in Table 1. Means of age at UC 
onset among the case and control participants were 
Table 1. Details of Baseline Demography, Risk Factors, and Diseases
Variable %Total
Case (n = 27) Control (n = 54)
P Value
No. (%) No. (%)
Gender 
Male 54.3 17 (38.6) 27 (61.4)
0.27
Female 43.7 10 (27.0) 27 (73.0)
Marital status 
Single 8.6 4 (57.1) 3 (42.9)
0.16
Married 91.4 23 (31.3) 51 (68.9)
Education
< Diploma 66.7 17(31.5) 37 (68.5)
0.61
>Diploma 33.3 10 (37) 17 (63)
History of diabetes 
Yes 91.4 24 (32.4) 50 (67.6)
0.57
No 8.6 3 (42.9) 4 (57.1)
History of hypertension 
Yes 88.9 26 (36.1) 46 (63.9)
0.13
No 11.1 1 (11.2) 8 (88.9)
History of fatty liver disease 
Yes 80.2 20 (30.8) 45 (69.2)
0.32
No 19.8 7 (43.8) 9 (56.2)
History of thyroid diseases 
Yes 88.9 23 (31.9) 49 (68.1)
0.45
No 11.1 4 (44.4) 5 (55.6)
History of kidney stones 
Yes 72.8 21 (35.6) 38(64.4)
0.48
No 27.2 6 (27.3) 16 (72.7)
Depression
Yes 88.9 24 (33.8) 47 (66.2)
0.81
No 11.1 3 (30.0) 7 (70.0)
Sleep time
Before 23:00 59.3 12 (25.0) 36 (75.0)
0.05
After 23:00 40.7 15 (45.5) 18 (54.5)
Wake-up time in the morning
Before 6: 00 52.6 12 (29.3) 29 (70.7)
0.76
After 6: 00 47.4 12 (32.4) 25 (67.6)
Permanent use of piped water
Yes 73.1 16 (28.1) 41 (71.9)
0.39
No 26.9 8 (38.1) 13 (61.9)
Night shift work
Yes 10.3 5 (62.5) 3 (37.5)
0.04
No 89.7 19 (27.1) 51 (72.9)
Age at disease onset (y) (Mean ± SD) - 41.74 (7.91) 44.94 (6.67) <0.01
Night-time sleep duration (h) (Mean ± SD) 7.14 (1.88) 7.40 (2.35) 7.01 (1.60) 0.38
Diastolic blood pressure (Mean ± SD) - 94.00 (13.71) 95.20 (11.23) 0.66
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41.74 years (SD: 7.16 years) and 44.94 years (SD: 6.67 
years), respectively (P value < 0.01). Majority of the study 
participants were male (44 vs. 37); while 32.4% of cases 
and 67.6% of controls were married (P value = 0.27), with 
less than diploma degree (31.5% for cases and 68.5% for 
controls, P value = 0.61). 
The normal diastolic blood pressures were 94.0 mmHg 
and 95.2 mmHg for the case and control participants, 
respectively (P value = 0.66); 91.4% had a history of 
diabetes (32.4% for cases and 67.6% for controls, P 
value = 66), 88.9% had a history of hypertension (36.1% 
for cases and 73.9% for controls, P value = 0.13), 80.2% 
had a history of fatty liver disease (30.8 for cases and 
69.2% for controls, P value = 0.32), 88.0% had a history 
of thyroid disease (31.9% for cases and 68.1% for controls, 
P value = 0.45), 72.8% had a history of kidney stones 
(35.6% for cases and 64.4% for controls, P value = 0.48), 
and 88.9% had experience of depression (33.8% for cases 
and 66.3% for controls, P value = 0.13). 
The sleep time for 40.7% of participants was after 23 
o’clock (45.5 % for cases and 54.5% for controls, P value = 
0.05) and wake-up time in the morning for 47.4% of 
them was after 6 o’clock (32.4% for cases and 67.6% for 
controls, P value = 0.76). The mean sleep duration was 
7.14 ± 1.88 hours per night, with a mean of 7.01 ± 1.60 for 
the control subjects and 7.40 ± 2.35 hours of sleep per 
night for UC subjects. Overall, there were no significant 
differences between the two groups in terms of the risk 
factors.
Univariate and Multiple Analysis of Risk Factors for UC 
Demographic characteristics of the study participants and 
related risk factors are shown in Table 2. Based on the 
univariate analysis, there was no significant correlation 
between UC and any of the factors of gender, marital 
Table 2. Risk factors Associated With Ulcerative Colitis in the Study Participants 
Variable %
Univariate OR 
(95% CI)
P Value
Adjusted OR (95% 
CI)
P Value
Gender 
Male 54.32 Ref -
Female 45.68 1.70 (0.66-4.37) 0.27 -
Marital status
Single 8.64 Ref Ref Ref
Married 91.36 0.33 (0.07-1.63) 0.17 0.68 (0.11-4.24) 0.68
Education 
Less than a diploma degree 66.66 Ref Ref 
Diploma degree and higher 33.34 1.28 (0.46-3.37) 0.67 -
History of diabetes
No 8.64 Ref 0.57 -
Yes 91.36 0.13 (0.13-3.08) -
History of hypertension 
No 88.88 Ref Ref 
Yes 11.12 4.52 (0.53-38.19) 0.16 3.13 (0.34-28.48) 0.30
Permanent use of piped water
Yes 74.00 Ref -
No 26.00 1.57 (0.55-4.52) 0.39 -
Night shift work
No 86.41 Ref Ref 
Yes 13.59 4.47 (0.97-20.56) 0.05 3.82 (0.71-20.55) 0.11
History of thyroid diseases
No 11.11 Ref -
Yes 88.89 0.58 (0.14-2.39) 0.45 -
Depression 
No 12.34 Ref -
Yes 87.66 1.19 (0.28-5.02) 0.81 -
History of fatty liver disease 
No 19.75 Ref -
Yes 80.25 0.57 (0.18-1.75) 0.32 -
History of kidney stones
No 72.83 Ref -
Yes 27.17 1.47 (0.50-4.33) 0.48 -
Sleep time
Before 23:00 59.25 Ref Ref 
After 23:00 40.75 2.50 (0.97-6.44) 0.58 2.10 (0.72-6.06) 0.16
Wake-up time in the morning
Before 6:00 50.61 Ref -
After 6:00 49.39 1.16(0.44-3.03) 0.72 -
Age at disease onset (y) 0.92 (0.85-1.00) 0.06 0.93 (0.85-1.01) 0.11
Night-time sleep duration (Mean ± SD) 1.11 (0.87-1.43) 0.38 -
Systolic blood pressure (Mean ± SD) 0.99 (0.95-1.03) 0.65 -
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status, education, diastolic blood pressure, history of 
diabetes, history of hypertension, permanent use of piped 
water, night shift work, history of thyroid diseases, 
depression, history of fatty liver disease, history of kidney 
stones, and sleep time and wake-up time in the morning. 
As can be seen in the univariate analysis, age at disease 
onset had a protective effect on UC (OR = 0.92, 95% CI: 
0.85-1.00). The variables of marital status, history of 
hypertension, night shift work, and sleep time (Table 2) 
with a P value less than 0.2 in univariate analysis were 
entered into the multiple regression analysis, though no 
significant correlations were found between them and UC. 
Discussion 
Exploring UC risk factors would be a great opportunity 
to advance our understanding of disease pathogenesis 
by investigating this aspect when the disease is newly 
emerging. The present study showed that there were no 
significant correlations between UC and gender, marital 
status, education, diastolic blood pressure, history of 
diabetes, history of hypertension, permanent use of 
piped water, night shift work, history of thyroid diseases, 
depression, history of fatty liver disease, history of kidney 
stones, sleep time, wake-up time in the morning, and 
night-time sleep duration. 
Moreover, no significant differences were observed 
between UC patients and control subjects in terms of 
education and marital status in this study. Likewise, 
no significance difference was found in some previous 
studies between UC cases and control subjects regarding 
education and marital status.11,12 Furthermore, there was 
no difference in gender distribution between cases and 
controls in the present study; this result agreed with that of 
a study by Ng et al.13 The association between interrupted 
sleep and IBD might be bidirectional, such that whilst 
poor sleep quality might exacerbate IBD, increased 
disease activity in turn might disrupt the sleep. Both 
reduced and prolonged duration of sleep were associated 
with increased risk of UC.14 Several observational studies 
have found an increased prevalence of sleep disruption in 
IBD.14-16 However, according to the results of the present 
study, there was no significant correlation between UC 
and sleep duration; this result consisted with that of the 
study of Ananthakrishnan et al.17 Thus, it is possible that 
sleep quality as an environmental variable does not truly 
impact the UC. Further studies are warranted to evaluate 
the impact of sleep quality on the disease outcomes in 
patients with UC. Additionally, in this study there was no 
significant difference in terms of history of thyroid disease 
between the cases and controls. This result corroborated 
that of Bianchi et al.18 in that there was no diﬀerence 
between UC patients and control subjects, although 
enlargement of the thyroid gland occurred more often in 
CD patients compared to the control subjects. Similarly, 
the study of Neubauer et al19 reported that enlargement of 
the thyroid gland was observed more commonly in UC 
patients than in control individuals. Furthermore, the 
study of Tsai et al20 demonstrated a higher proportion of 
prior hyperthyroidism among UC patients compared to 
the control subjects.
Many studies have documented that UC is a multifactorial 
disease.21,22 For example, a previous study mentions that 
genetic expressions, immune responses, environmental 
factors, and patient lifestyle might play major roles in the 
incidence of UC.21,23 Thus, further studies are necessary to 
better understand the other risk factors and environmental 
determinants of UC. 
Limitations
We are aware that a number of limitations might have 
influenced the obtained results. A main plausible error 
of the study is that it was a retrospective study, relying 
on recall of participants’ events and ingestions. There 
is a potential recall bias on some variables such as sleep 
time, wake-up time in the morning, and night-time sleep 
duration. 
The second limitation of this study is the small number of 
cases. Therefore, the association found between risk factors 
and prevalence of UC needs to be tested in larger samples. 
The low sample size may reduce the statistical power to 
demonstrate a difference.
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